| Literature DB >> 27149641 |
Jun Yan1, Jie Chen1, Shun Zhang1, Jinhui Hu1, Ling Huang1, Xingshu Li1.
Abstract
Twenty-nine novel indole-chalcone derivatives were synthesized and evaluated for antiproliferative activity. Among them, 14k exhibited most potent activity, with IC50 values of 3-9 nM against six cancer cells, which displayed a 3.8-8.7-fold increase in activity when compare with compound 2. Further investigation revealed 14k was a novel tubulin polymerization inhibitor binding to the colchicine site. Its low cytotoxicity toward normal human cells and nearly equally potent activity against drug-resistant cells revealed the possibility for cancer therapy. Cellular mechanism studies elucidated 14k arrests cell cycle at G2/M phase and induces apoptosis along with the decrease of mitochondrial membrane potential. Furthermore, good metabolic stability of 14k was observed in mouse liver microsomes. Importantly, 14k and its phosphate salt 14k-P inhibited tumor growth in xenograft models in vivo without apparent toxicity, which was better than the reference compound CA-4P and 2. In summary, 14k deserves consideration for cancer therapy.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27149641 DOI: 10.1021/acs.jmedchem.6b00021
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446